In THSD7A-ab positive patients antigen-specific IgG1, IgG2, and IgG3 were found in 65, 21, and 62% of cases with primary MN vs. 71, 29, and 86% of cases with malignancy-associated MN, respectively (Figure 1C). The gene discussed is IGHG3; the disease is cancer.